Karin Shanahan is Executive Vice President, Global Product Development & Supply, Bristol-Myers Squibb, where she oversees worldwide product development, manufacturing, and supply. Global Product Development & Supply develops and produces active ingredients and drug products and delivers the company’s medicines throughout the world.  

Karin began her career in the pharmaceutical industry at Bristol Myers Squibb in corporate procurement, global supply chain, and global quality. She moved into manufacturing operations, leading two manufacturing sites in Billerica, Massachusetts, and Latina, Italy. After almost 14 years with Bristol Myers Squibb, Karin joined Becton-Dickenson as a leader of global operations, followed by Catalent Pharmaceuticals, where she led global Biologics operations. In 2013, Karin joined Teva Pharmaceuticals as Senior Vice President and Chief Operating Officer of Global Operations, where she led global Manufacturing Science & Technology (MS&T) and Network Strategy and a network of 25 sites across Europe and the Americas. Most recently, Karin served as Senior Vice President of Global Biologics & Sterile Operations at Merck & Co., Inc.

Karin earned a bachelor’s degree in political science and international relations from Rutgers University and a master’s degree in jurisprudence (MSJ), pharmaceutical and device law, from Seton Hall Law School.  

Sessions

Executive Insights: Weathering the Storm – The Path Forward in Optimizing Supply Practices